SP-MHCI-0654-3

Human Telomerase reverse transcriptase 461-469, VYGFVRACL

US$507.00

In stock

Description

About Human Telomerase reverse transcriptase 461-469, VYGFVRACL

The Human Telomerase reverse transcriptase Peptide (IEDB: 99851) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Telomerase reverse transcriptase Peptide, H-VYGFVRACL-OH (Uniprot: O14746 aa: 461-469) from JPT is produced under strict quality control and quality management.

Human Telomerase reverse transcriptase 461-469, VYGFVRACL - Specifications

  • Peptide sequence: H-VYGFVRACL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Melanoma, Hepatocellular carcinoma,
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Telomerase reverse transcriptase 461-469, VYGFVRACL

References:
Read References with JPT’s Antigen Peptides
Human Telomerase reverse transcriptase 461-469, VYGFVRACL has been described in:
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma., Elife, 2020 (PMID: 32314731)
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma., Immunity, 2021 (PMID: 34270940)
Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy., Cancer Res, 2005 (PMID: 16024648)

Documentation

Documentation for Human Telomerase reverse transcriptase 461-469, VYGFVRACL

Properties

Properties of Human Telomerase reverse transcriptase 461-469, VYGFVRACL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Hepatocellular carcinoma, Melanoma
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Telomerase reverse transcriptase
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Telomerase reverse transcriptase 461-469, VYGFVRACL

Information Values
Sequence: H-VYGFVRACL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote